• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Sunday, October 19, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Biology

Bioengineering & Translational Medicine honors biotech pioneers Langer and Peppas

Bioengineer by Bioengineer
January 18, 2019
in Biology
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

January 2019 issue of fully gold open-access journal showcases advances in drug delivery and biomaterials inspired by the honorees

Hoboken, N.J–January 18, 2019–Bioengineering & Translational Medicine (BioTM), published by Wiley on behalf of the American Institute of Chemical Engineers (AIChE) and its Society for Biological Engineering (SBE), has released a tribute issue dedicated to research inspired by Robert Langer and Nicholas Peppas — two biotechnology luminaries whose game-changing contributions to drug delivery and biomaterials have made those fields integral elements of modern chemical engineering research and education.

Robert Langer, the David H. Koch Institute Professor at the Massachusetts Institute of Technology (MIT), established in his early career that proteins could be encapsulated in polymeric matrices and released in a sustained manner, and went on to invent many new biomedical technologies for drug delivery, as well as pioneering tissue engineering techniques for regenerative medicine. Nicholas Peppas, the Cockrell Family Regents Chaired Professor in Engineering, Medicine and Pharmacy at the University of Texas at Austin, established the quantitative principles for describing drug release from porous matrices and hydrogels, and his subsequent work in biomaterials and bionanotechnology has spawned many biomedical breakthroughs.

In a forward to the tribute issue, Aaron C. Anselmo, from the University of North Carolina at Chapel Hill, writes that the efforts of Langer and Peppas — individually and taken together — “have shaped the scholastic, academic, and technological landscape of drug delivery and biomaterials as we know them today.” Anselmo adds that Langer’s and Peppas’s pioneering research, along with their prominent leadership, “has advanced the visibility of drug delivery and biomaterials in the scientific landscape, especially within chemical engineering, and has inspired young professionals to follow their paths. The work featured in this issue provides a snapshot of the exciting work that has been inspired by them.”

Samir Mitragotri, Editor-in-Chief said, “It’s a privilege to honor Nicholas Peppas and Robert Langer in a special issue of BioTM. These two pioneers of drug delivery and biomaterials established the vision for the field, and brought it to the forefront through scholarly research, innovative technologies and inspirational mentorship to several generations of trainees.”

The January 2019 tribute issue of BioTM (Vol. 4, Issue 1) contains research articles from some of Langer’s and Peppas’s former students, as well as colleagues and admirers. The issue is freely available to read, download and share from Wiley Online Library at http://www.bioengtransmed.com.

Launched in 2015, BioTM journal focuses on the fundamental ways chemical and biological engineering approaches drive and provide innovative technologies and solutions that impact clinical practice and/or commercial healthcare products. Visit the journal website for more information.

###

Additional Information

Media Contacts

AIChE:

Gordon Ellis (US) +1 646-495-1348

[email protected]

Wiley:

Josh Glickman (US) +1 201-748-6572

[email protected]

Follow us on Twitter @WileyNews

About SBE

Established in 2004, the Society for Biological Engineering is a technological community for engineers and applied scientists integrating biology with engineering. Members of SBE come from a broad spectrum of industries and disciplines and share in SBE’s mission of realizing the benefits of bioprocessing, biomedical and biomolecular applications. http://bio.aiche.org.

About AIChE

AIChE is a professional society of more than 60,000 chemical engineers in 110 countries. Its members work in corporations, universities and government using their knowledge of chemical processes to develop safe and useful products for the benefit of society. Through its varied programs, AIChE continues to be a focal point for information exchange on the frontiers of chemical engineering research in such areas as energy, sustainability, biological and environmental engineering, nanotechnology and chemical plant safety and security. More information about AIChE is available at http://www.aiche.org.

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company’s website can be accessed at http://www.wiley.com.

Media Contact
Josh Glickman
[email protected]
201-748-6000
https://newsroom.wiley.com/press-release/all-corporate-news/bioengineering-translational-medicine-honors-biotech-pioneers-rober

Tags: Biomedical/Environmental/Chemical EngineeringBiotechnologyTechnology/Engineering/Computer Science
Share12Tweet8Share2ShareShareShare2

Related Posts

blank

Sex Differences in Anxiety and Depression Modulation

October 19, 2025
blank

Ovarian Hormones Curb Fear Relapse via Dopamine Pathway

October 18, 2025

RNA Sequencing Uncovers Bovine Embryo Activation Regulators

October 18, 2025

Placental DNA Mutations, Stress, and Infant Emotions

October 18, 2025
Please login to join discussion

POPULAR NEWS

  • Sperm MicroRNAs: Crucial Mediators of Paternal Exercise Capacity Transmission

    1262 shares
    Share 504 Tweet 315
  • Stinkbug Leg Organ Hosts Symbiotic Fungi That Protect Eggs from Parasitic Wasps

    290 shares
    Share 116 Tweet 73
  • New Study Suggests ALS and MS May Stem from Common Environmental Factor

    124 shares
    Share 50 Tweet 31
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    103 shares
    Share 41 Tweet 26

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Novice Nurses’ Role in Workplace Adaptation: Study Insights

Revealing Aging Changes in Renal Tubulointerstitium

Reversing Cellular Aging: PURPL RNA’s Epigenetic Breakthrough

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 65 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.